Functional high-resolution time-course expression analysis of human embryonic stem cells undergoing cardiac induction  by Piccini, Ilaria et al.
Genomics Data 10 (2016) 71–74
Contents lists available at ScienceDirect
Genomics Data
j ourna l homepage: www.e lsev ie r .com/ locate /gdataData in BriefFunctional high-resolution time-course expression analysis of human
embryonic stem cells undergoing cardiac inductionIlaria Piccini a, Marcos Araúzo-Bravo b,c, Guiscard Seebohm a, Boris Greber d,e,⁎
a Institute of Genetics of Heart Diseases (IfGH), Department of Cardiovascular Medicine, University Hospital Münster, Münster, Germany
b Group of Computational Biology and Systems Biomedicine, Biodonostia Health Research Institute, 20014 San Sebastián, Spain
c IKERBASQUE, Basque Foundation for Science, 48009 Bilbao, Spain
d Human Stem Cell Pluripotency Laboratory, Max Planck Institute for Molecular Biomedicine, Münster, Germany






⁎ Corresponding author at: Max Planck Institute for
Esmarch-Straße 54, D-48149 Münster, Germany.
E-mail address: boris.greber@mpi-muenster.mpg.de (
http://dx.doi.org/10.1016/j.gdata.2016.09.007
2213-5960/© 2016 The Authors. Published by Elsevier Inca b s t r a c ta r t i c l e i n f oArticle history:
Received 5 September 2016
Accepted 26 September 2016
Available online 28 September 2016Cardiac induction of human embryonic stem cells (hESCs) is a process bearing increasingmedical relevance, yet it
is poorly understood from a developmental biology perspective. Anticipated technological progress in deriving
stably expandable cardiac precursor cells or in advancing cardiac subtype speciﬁcation protocols will likely re-
quire deeper insights into this fascinating system. Recent improvements in controlling hESC differentiation
now enable a near-homogeneous induction of the cardiac lineage. This is based on an optimized initial stimula-
tion of mesoderm-inducing signaling pathways such as Activin and/or FGF, BMP, andWNT, followed byWNT in-
hibition as a secondary requirement. Here, we describe a comprehensive data set based on varying hESC
differentiation conditions in a systematicmanner and recording high-resolution differentiation time-courses an-
alyzed by genome-wide expression proﬁling (GEO accession number GSE67154). As a baseline, hESCs were dif-
ferentiated into cardiomyocytes under optimal conditions. Moreover, in additional time-series, individual
signaling factorswerewithdrawn from the initial stimulation cocktail to reveal their speciﬁc roles via comparison
to the standard condition. Hence, this data set presents a rich resource for hypothesis generation in studying
human cardiac induction, as we reveal numbers of known aswell as uncharacterized genes prominentlymarking
distinct intermediate stages in the process. These data will also be useful for identifying putative cardiac master
regulators in the human system as well as for characterizing expandable cardiac stem cells.Molecular Biomed
B. Greber).
. This is an open ac© 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-
NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).(1. Direct link to deposited dataSpeciﬁcationsrganism/cell
line/tissueHomo sapiens/hESC line HuES6/Differentiating human embryonic
stem cellsx Female
quencer or
array typeHumanHT-12 v4Cata format Raw and processed
Saxperimental
factors
Variation of cell signaling factor stimulation; Time-course
expression proﬁling at daily intervals during hESC differentiationxperimental
featureshESCs maintained in chemically deﬁned culture medium were
replated at high density and simultaneously treated with cardiac
mesoderm-inducing factors for one day (20 ng/ml FGF2, 1 ng/ml
BMP4, 1 μM CHIR99021). At 48 h, the differentiating cells were
treated with WNT inhibitor IWP-2 for 2 days (2 μM). Overall
differentiation was performed on Matrigel-coated plates in
chemically deﬁned medium devoid of serum, serum albumin,icine, Von-
cess article under thcontinued)Speciﬁcationse CC BY-NC-ND liceninsulin, and complex additives.
Furthermore, for investigating the signiﬁcance of stimulating the
three pathways at the beginning of the protocol, three additional
time-series were recorded. In these, one signaling factor each was
omitted from the initial stimulation cocktail, to reveal its
signiﬁcance for cardiac induction through comparison against the
standard condition, respectively.onsent Not applicable
mple source
locationMünster, GermanyDeposited data can be found here: http://www.ncbi.nlm.nih.gov/geo/
query/acc.cgi?acc=GSE67154.
2. Experimental design, materials and methods
2.1. Generation and processing of samples
hESCs, cell line HuES6 [1], were maintained in FTDA medium [2], on
Matrigel™-coated dishes. Cardiac differentiation was induced asse (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1.Basic analysis of standard cardiac induction time-course. (A) Illustration of the signaling factor treatment protocol used for promoting cardiac induction. (B) Global correlation-based
dendrogramof the time-course samples; r= linear transcriptome correlation coefﬁcient. (C) Clustering of gene sets according to temporal expression kinetics. Selected representatives of
each cluster are plotted on the left. Error bars indicate bead standard deviation. Selected annotation terms revealed by GREAT are shown on the right along with corresponding P values.
72 I. Piccini et al. / Genomics Data 10 (2016) 71–74described [3]. In brief, fully conﬂuent hPSC cultures were harvested
using Accutase™, and replated onto Matrigel-coated 24-well plates
(500,000 cells per well in 2 ml of day 0 differentiation medium). An al-
iquot of cells was used for RNA isolation (“day 0” = undifferentiated
hESCs). Day 0 differentiationmedium contained Knockout™DMEM, in-
sulin/transferrin/selenium, 10 μM Y27632, penicillin/streptomycin/L-
Glutamine, 20 ng/ml FGF2, 1 ng/ml BMP4, and 1 μM CHIR99021 (3 -
standard condition). Alternatively, FGF2, BMP4, or CHIR were selective-
ly omitted from the signaling stimulation cocktail (factor withdrawal
time-courses). Day 1 medium contained Knockout™ DMEM, transfer-
rin/selenium, penicillin/streptomycin/L-Glutamine, and 250 μMphospho-ascorbate (“TS medium”). On days 2 and 3, cells were fed
with TS medium supplemented with 2 μM of WNT inhibitor IWP-2
(Fig. 1A). Hence after, cells were maintained in basal TS medium. Spon-
taneous beating was observed from day 6 onwards. CM differentiation
efﬁciency in the standard time-coursewas approximately 90% as judged
by FACS analysis for cardiac troponin T [4]. Samples were collected from
replicate cultures at daily intervals. Total RNAwas isolated using Qiagen
RNeasy columns with on-column DNA digestion.
500 ng of total RNA from each biological sample were used as input
for the generation of biotin-labelled cRNA using an Illumina® TotalPrep
™ RNA ampliﬁcation kit (Life Technologies). Following the
Fig. 2. Signaling factor withdrawal time-courses. (A) Protocol illustrations (top) and hierarchical clustering of ~300 genes across all indicated samples. Designations of major clusters and
key representative genes are given on the right. (B) Functional annotation based on enriched gene expression in all day 8 samples using GREAT. (C) Representative genes of color-coded
clusters highlighted in part A. Note that the selected set of cardiac precursor genes becomes expressed in all time-series by day 8, whereas terminal differentiation fate differs as shown in
the “terminal cardiac” and “neural crest” charts. Error bars indicate bead standard deviation.
73I. Piccini et al. / Genomics Data 10 (2016) 71–74manufacturer's instructions, in-vitro transcription of double-stranded
cDNA was performed for 14 h in a PCR cycler. Puriﬁed biotin-labelled
cRNA was eluted in a volume of 100 μl and quality-checked on a 2100
Bioanalyzer device (Agilent Technologies). cRNA sampleswere adjusted
to 150 ng/μl in water, and hybridized onto Illumina HumanHT-12 v4
bead arrays following the manufacturer's instructions throughout.
Hybridization was carried out at 58 °C for 18 h. Staining with
streptavidin-Cy3 (GE Healthcare #PA43001) was carried out as recom-
mended, at a concentration 1 μg/ml in blocking buffer. Dried bead arrays
were scanned on a HiScan SQ device (Illumina) using default settings.2.2. Technical and biological data quality assessment
Scanned images were conﬁrmed to show an overall clean ﬂuores-
cence spot morphology with high signal-to-noise ratio, and array data
were conﬁrmed to display an average P95 intensity of N700 (a.u.). In-
spection of rawdata in GenomeStudio suggested anoverall high hybrid-
ization stringency, according to internal mismatch control probes, and
nomajor hybridization artifacts. Following these routine checks, all sep-
arately hybridized samples were background-subtracted and normal-
ized using the Cubic Spline algorithm in GenomeStudio. Processeddata were ﬁltered in MS Excel by setting experience-based thresholds
for expression changes and minimal gene expression levels.
For instance, clusters in Fig. 1Cwere deﬁned as follows: Peak expres-
sion level N 10-fold compared to at least one of the other time-points;
Absolute expression level N 300 (a.u.). Similarly, the gene set underlying
Fig. 2Awas deﬁned by a N20-fold enrichment on either day 0, day 2, day
4, or day 8, while requiring an absolute signal intensity of N500 (a.u.).
Hierarchical clustering of genes was performed with standardized Eu-
clidean metrics and the Ward linkage method [5]. For functional anno-
tation of ﬁltered gene sets, employing the Ensembl BioMart interface,
array probe sequences were converted into GRCh37/hg19 genome co-
ordinates which were then used as input for GREAT analysis [6]. Statis-
tically signiﬁcant hits were subjectively ﬁltered for biological relevance.
Expression levels of individual genes are presented as array intensity
signals ± bead standard deviation.
As a biological quality control step, knownmarkers were used to as-
sess differential gene expression between samples. In line with the ex-
pectations, hPSC-speciﬁc genes like OCT4, NANOG and SOX2 were
gradually downregulated under standard conditions, albeit with dis-
tinct kinetics [4]. Conversely, most known cardiac markers like MYH6,
NKX2.5, and TNNT2 were only induced under standard cardiac and, to
a lesser degree, under FGF2 withdrawal conditions. Accordingly, the
74 I. Piccini et al. / Genomics Data 10 (2016) 71–74latter samples only yielded a partially beating layer of cells towards the
end of the time-course, whereas the BMP andWNTwithdrawal cultures
did not display any spontaneous beating. Furthermore, as already indi-
cated, FACS analysis conﬁrmed near-homogeneous differentiation into
cardiomyocytes in the standard time-course. In addition, RT-qPCR anal-
yses of independent experiments suggested an overall high degree of
consistency and reproducibility with regards to kinetic proﬁles of
stage-speciﬁc marker genes (data not shown).
2.3. Basic data analysis
Standard cardiac induction time-course. Fig. 1B shows a dendrogram
based on global correlation analysis of the standard time-course sam-
ples. Of note, the day 5 to 8 samples formed a distinct cluster suggesting
that as early as on day 5, the cells may already have reached a state sim-
ilar to theirﬁnal cardiomyocyte fate. In linewith this idea, upon deﬁning
stage-speciﬁc clusters, we failed to identify a clear d5-speciﬁc gene ex-
pression signature. Hence, clusters were deﬁned based on the day of
peak expression - day 0, 1, 2, 3, or 4 -with the exception of theﬁnal clus-
ter (“peak on days 5–8”). Fig. 1C shows the kinetic proﬁles of a number
of “lead representative genes” and lists additional members, together
with cluster-speciﬁc functional annotation. Not surprisingly, the ﬁrst
cluster was highly enriched for hESC-speciﬁc genes and their downreg-
ulation illustrates the loss of pluripotency in response to signaling
changes (Fig. 1A). Interestingly, some genes such as PRDM14 displayed
extremely rapid downregulation kinetics, perhaps suggesting a direct
regulation by the BMP/WNT signaling pathways as in case of SOX2 [4].
Subsequently, based on unbiased functional annotation, the cells
rapidly passed through physiological intermediate stages which we
termed early “primitive streak-like”, “mesoderm”, and “lateral plate
mesoderm-like”. Lead representatives of these clusters were prominent
transcriptional regulators such asMIXL1/CDX1/SP5 (peaking on day 1),
MESP1/T/EOMES (day 2), and HAND1/SNAI2/IRX3 (day 3), respectively
(Fig. 1C). However, this ﬁgure also lists a number of uncharacterized
genes that may warrant further investigation in the context of identify-
ing cardiac master regulators, for instance. As early as by day 4, the dif-
ferentiating hESCs then reached a cardiac precursor-like state marked
by ISL1, PDGFRA, and MEIS2 which are well-known genes acting in
multipotent cardiac progenitors [7–9]. Accordingly, from day 5 - or
even from day 4 in some cases - various regulatory and structural car-
diomyocyte-speciﬁc genes like NKX2.5,MYH6 (encoding myosin heavy
chain 6), and TNNT2 (cardiac troponin T) became upregulated to sub-
stantial levels, to cause a spontaneous beating phenotype by day 6
(Fig. 1C, last cluster).
Factor withdrawal time-courses. Fig. 2A illustrates this exciting
course of events at a more global scale, by highlighting expression pro-
ﬁles of approximately 300 marker genes. In addition, this ﬁgure also
contains the signaling factor withdrawal time-courses, which allows
to assess the importance and roles of ActA/FGF, BMP, andWNT stimula-
tion at the very beginning of differentiation (see corresponding signal-
ing treatments in the top panel of the ﬁgure). Hierarchical clustering
of the ﬁltered gene set revealed that BMP orWNTwithdrawal essential-
ly disabled all differentiation into cardiomyoctes, whereas omitting
ActA/FGF from the day 0 stimulation cocktail only compromised cardiac
induction without abolishing it entirely (see “terminal cardiac” cluster
in Fig. 2A). Accordingly, the standard as well as the no-ActA/FGF time-
courses yielded annotation terms closely linked to cardiomyocyte dif-
ferentiation, whereas these results were statistically less signiﬁcant in
case of the ActA/FGF withdrawal time-series (Fig. 2B).
In comparison, the no-BMP and no-WNT time-courses displayed a
delayed loss of pluripotency gene expression. Moreover, many - albeit
interestingly not all - cardiac progenitor genes failed to become induced
even until day 8 of differentiation. Instead, we noticed an induction of a
small but prominent set of neural crest-associated genes in the BMP andWNTwithdrawal samples, suggesting a redirection into this alternative
differentiation fate (see “neural crest” cluster in Fig. 2A). This interpre-
tationwas also supported by functional annotation terms like “craniofa-
cial development”, “muscle phenotype”, and “skeleton phenotype” (Fig.
2B). To substantiate these observations, Fig. 2C highlights the expres-
sion of keymarkers representing the aforementioned lineages: Striking-
ly, the d8 no-BMP and no-WNT samples seemed to coexpress neural
crest genes TFAP2A/EYA2/DLX5 and cardiac precursor genes ISL1/
MEIS2/HAND1, although this could also reﬂect heterogeneous differenti-
ation in these cultures. In comparison, the standard cardiac time-course
did not show any neural crest-like side-products, but the no ActA/FGF
cultures displayed an intermediate phenotype characterized both by
cardiomyocyte and neural crest-like cell identity (Fig. 2C).
3. Discussion
Our expression time-course analysis illustrates how deﬁned pertur-
bations of a few signaling pathways may induce a complex develop-
mental program leading to the conversion of pluripotent human stem
cells into beating cardiomyocyte-like cells within less than one week.
This truly remarkable and medically relevant system is poorly studied
at present, but the data set introduced here may serve as a useful re-
source for identifying important - and novel - players in this context. In-
deed, in addition to prominent loci known from developmental studies
in model organisms, the stage-speciﬁc intermediate clusters also con-
tain a number of uncharacterized genes including, for instance, long
non-coding RNAs.
Moreover, the signaling factor withdrawal time-courses reveal the
importance of each of the extrinsic initiation factors of cardiac induc-
tion. Our analysis conﬁrms that the stimulation of the BMP and WNT
cascades ismost crucial for promoting a cardiomyocyte identify, where-
as the FGF and/or Activin/TGFβ pathways play a more accessory role [3,
4]. Somewhat surprisingly, though, both BMP and WNT withdrawal on
day 0 still permitted an upregulation of several cardiac progenitor
markers. However, some of these - like HAND1 for example - interest-
ingly play dual roles both in cardiac mesoderm and in neural crest in-
duction. Perhaps for this reason, neural crest appeared to be a major
differentiation fate competingwith cardiac induction in our experimen-
tal setting.
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